FDLI Committees
As a membership organization, the Food and Drug Law Institute depends on the dedication and commitment of its members to ensure the vitality of association programs. Each year, hundreds of members serve on the Institute's standing committees.
FDLI committees consist of volunteer members who assist in formulating and implementing policies and strategies consistent with the organization’s mission.
If you are a member in good standing and would like to inquire about joining a committee please contact FDLI to learn more.
The Academic Programs Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the academic legal community. The Committee discusses various programs, publications, pricing, dissemination vehicles, etc. that best facilitate expanding FDLI’s educational mission.
Judith Meritz, Baker, Donelson, Bearman, Caldwell & Berkowitz, PC
Chair
Ralph Hall, University of Minnesota
Vice Chair
Barry Berger, GlaxoSmithKline
Annemarie Boyan, Drexel University
James Czaban, Wiley Rein LLP
Lewis Grossman, Covington & Burling LLP
William Janssen, Charleston Law School
Philip Katz, Hogan & Hartson, LLP
Eleanor Kinney, Indiana University School of Law - Indianapolis
William Kitchens, Arnall Golden Gregory LLP
Francis Palumbo, University of Maryland School of Pharmacy
Peter Safir, Covington & Burling LLP
Sheila Shulman, State University of NY at Buffalo
Victoria Sutton, Texas Tech University
Roseann Termini, Widener University School of Law
Geoffrey Levitt, Wyeth Pharmaceuticals
Chair
James Czaban, Wiley Rein LLP
Coleen Klasmeier, Sidley Austin LLP
Stuart Land, Arnold & Porter LLP
The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.
James Czaban, Wiley Rein LLP
Chair
Bruce Patsner, University of Houston
Vice Chair
Thomas Colonna
Lewis Grossman, Covington & Burling LLP
David Gryte, Astrazeneca Pharmaceuticals
Christina Markus, King & Spalding, LLP
Christine Mulshine, Children's Medical Center-Ambulatory Care Pavilion
Deborah Shelton, Sheppard, Mulllin, Richter & Hampton, LLP
The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.
Philip Katz, Hogan & Hartson, LLP
Chair
Michael Bernstein, FDA - CDER
Paul Ferrari, Hyman, Phelps & McNamara, P.C.
Michael Gaba, Holland & Knight, LLP
Matthew Kyle, Millennium Medical Technologies, Inc.
Peter Mathers, Kleinfeld, Kaplan & Becker
Roseann Termini, Widener University School of Law
Matthew Van Hook, U.S. Pharmacopeia
Kirke Weaver, Merck & Co., Inc.
William Schultz, Zuckerman, Spaeder
Chair
Nancy Buc, Buc & Beardsley
Immediate Past Chair
Frederick Degnan, King & Spalding, LLP
Vice Chair
James Kelly, FDLI
President & CEO
Jeffrey Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel
Linda Suydam, Consumer Healthcare Products Association
Treasurer
Minnie Baylor-Henry, Deloitte & Touche LLP
Robert Brackett, Grocery Manufacturers Association
Mark DuVal, DuVal & Associates, P.A.
Mark Frankel, AAAS
Christopher Hagenbush, Patton Boggs LLP
Ralph Hall, University of Minnesota
Geoffrey Levitt, Wyeth Pharmaceuticals
Erika Lietzan, Covington & Burling LLP
Patricia Shrader, BD
John Taylor, Biotechnology Industry Organization
The Drugs and Biologics Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the drugs and biologics industries. The Committee advises staff on the appropriateness of conferences and publications relating to pharmaceuticals and biologics by reviewing and commenting on proposals.
Donald Beers, FDA - OCChair
Lesley Frank, FDA - CDER Guest
Jennifer Ross, FDA - CBER Guest
Bruce Artim, Eli Lilly and Company
Deborah Autor, FDA - CDER
Edward Berg, Sanofi-Aventis
Shawn Brown, Generic Pharmaceutical Association
Howard Dorfman, Ropes & Gray, LLP
Andrew Fish, Consumer Healthcare Products Association
Philip Katz, Hogan & Hartson, LLP
Patricia Knight, FoxKiser
Daniel Kracov, Arnold & Porter LLP
Scott Lassman, Kleinfeld, Kaplan & Becker
John Manthei, Latham & Watkins
Daniel Meron, Latham & Watkins
Joseph Metro, Reed Smith LLP
Sandra Milligan, Amgen Inc.
Sara Radcliffe, Biotechnology Industry Organization
The Journal Editorial Advisory Board promotes the educational, scholarly, and other purposes of the Food and Drug Law Journal. Members of the Board serve as peer reviewers for papers submitted for publication and recommend topics for “special / symposia” issues.
Jeffrey Chasnow, Pfizer, Inc.Chair
Anne Maher, Kleinfeld, Kaplan & BeckerVice Chair
Tracy Berns, Covidien
Krista Carver, Covington & Burling LLP
Kirk Dobbins, King & Spalding, LLP
Melanie Fairchild-Dzanis, Nestle USA-Nutrition Division
Jeffrey Francer, PhRMA
Michael Gaba, Holland & Knight, LLP
Ralph Hall, University of Minnesota
Joel Hoffman, Sutherland Asbill & Brennan, LLP
Gregory Jaffe, Center for Science in the Public Interest
Gail Javitt, Johns Hopkins University
Gordon Jepson, Deeth Williams Wall LLP
Kyle Lathrop, W.L. Gore and Associates
Laurie Lenkel, FDA - OC
Natasha Leskovsek, Cooley Godward Kronish LLP
Mark Levy, Saul Ewing LLP
Deborah Livornese, Buc & Beardsley
Suzanne LoGalbo, Novartis Consumer Health, Inc.
Maura Martin, Sidley Austin LLP
Eric Olsen, Mars, Inc.
James O'Reilly, Baker & Daniels
Mark Schwartz, FDA - OC
Sheila Shulman, State University of NY at Buffalo
Bradley Thompson, Epstein Becker & Green, P.C.
David Weinstock, Boehringer Ingelheim Pharmaceuticals
Frances Wu, Personal Care Products Council
The Update Editorial Advisory Board promotes the highest levels of professional, educational, and scholarly written commentary on timely issues of interest to professionals in the areas of foods, drugs, biologics, medical devices, other healthcare technologies, and cosmetics in FDLI’s magazine The Board serves as a resource for FDLI staff to develop feature theme ideas, acquire articles of interest to readers, and advise on the magazine’s quality and success in serving the interests and needs of its readers.
Robert Nicholas, McDermott, Will & EmeryChair
Barbara Binzak, Buchanan Ingersoll & Rooney PCVice Chair
Frederick Ball, Duane Morris LLP
Christopher Brown, Genentech, Inc.
Daniel Carmichael, Baker & Daniels
Megan Clark, FDA - OC
Elizabeth Fawell, Hogan & Hartson, LLP
Carrie Horn, Kleinfeld, Kaplan & Becker
William McGrath, Wiley Rein LLP
Stephanie Philbin, Goodwin Procter LLP
Rene Quashie, Drinker Biddle & Reath LLP
Larry Rosania, The Weinberg Group Inc.
Jeffrey Senger, FDA - OC
Sarah Vasani, King & Spalding, LLP
William Schultz, Zuckerman, Spaeder
Chair
Nancy L. Buc, Buc & Beardsley
Immediate Past Chair
Frederick Degnan, King & Spalding, LLP
Vice Chair
Jeffrey Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel
Linda A. Suydam, DPA, Consumer Healthcare Products Association
Treasurer
The purpose of the Finance Committee is to ensure the responsible financial operations of FDLI. The Committee provides on-going oversight of the financial operations and investment policies of FDLI to ensure sound financial management. The Committee also advises the Board on the direction and control of financial matters. The Committee also ensures that the Board is well informed about the Institute's finances.
Linda Suydam, Consumer Healthcare Products Association
Chair
Maxine Fritz, Quintiles Consulting
Rady Johnson, Pfizer, Inc.
Brenton Saunders, Schering-Plough Corporation
The Food and Dietary Supplements Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the food and dietary supplement industries. The Committee advises staff on the appropriateness of conferences and publications relating to foods and dietary supplements by reviewing and commenting on proposals.
Martin Hahn, Hogan & Hartson, LLPChair
Susan Bernard, FDA - CFSANGuest
Robert Post, Department of AgricultureGuest
R. Sowards, Texas Department of HealthGuest
Steven Armstrong, Campbell Soup Company
Nicole Coutrelis, Coutrelis & Associes
Todd Halpern, Wyeth Pharmaceuticals
Leslie Krasny, Keller and Heckman LLP
Rachel Lattimore, Arent Fox
Anne Maher, Kleinfeld, Kaplan & Becker
Steven Mister, Council for Responsible Nutrition
John Packman, The Coca-Cola Company
Steven Shapiro, Ullman, Shapiro & Ullman, LLP
Daniel Shaw, H.J. Heinz Company
Edward Steele, EAS Consulting Group, LLC
The Medical Devices Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the Medical Devices industries. The Committee advises staff on the appropriateness of conferences and publications relating to medical devices by reviewing and commenting on proposals.
Beverly Chernaik, FDA - OC
Chair
Philip Phillips, Becker & Associates Consulting, Inc.
Chair
Susan Alpert, Medtronic, Inc.
M. Elizabeth Bierman, Morgan, Lewis & Bockius, LLP
Mark Heller, Goodwin Procter LLP
Sheila Hemeon-Heyer, Boston Scientific Corporation Inc.
Charma Konnor, Phoenix Regulatory Associates, Ltd.
Mark Leahey, Medical Device Manufacturers Association
Joanne Less, FDA - OC
Carol Ley, 3M Company
Susan Moritz, BD
Steven Niedelman, Crowell & Moring LLP
Neil O'Flaherty, Olsson Frank Weeda Terman Bode Matz PC
Bradley Thompson, Epstein Becker & Green, P.C.
Casper Uldriks, FDA - CDRH
Mark DuVal, DuVal & Associates, P.A.Chair
Frederick Branding, McGuireWoods LLP
Marsha Cohen, Hastings College of the Law
Bruce Deal, Analysis Group, Inc.
R. Bruce Dickson, Manatt, Phelps & Phillips, LLP
Janice Hogan, Hogan & Hartson, L.L.P.
Paul Hyman, Hyman, Phelps & McNamara, P.C.
Leslie Krasny, Keller and Heckman LLP
Laurie Lenkel, FDA - OC
David Scharf, Baxter International Inc.
Daniel Shaw, H.J. Heinz Company
